Wittmer Michael H, Famuyide Abimbola O, Creedon Douglas J, Hartman Robert P
Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN 55902, USA.
AJR Am J Roentgenol. 2006 Oct;187(4):955-8. doi: 10.2214/AJR.05.0525.
The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion.
The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.
Essure微插入物是一种新的经美国食品药品监督管理局批准的避孕方法。本研究的目的是报告我们使用子宫输卵管造影术（HSG）评估其永久性输卵管阻塞疗效的初步经验。
Essure微插入物在所有患者中均导致输卵管阻塞。由于该装置可能会更广泛地使用，放射科医生应了解该装置的外观，并能够在子宫输卵管造影术上评估装置位置和输卵管阻塞情况。
